Inventor · disambiguated record
Björn Rosenstein
Also filed as: ROSENSTEIN BJÖRN
5 granted patents·5 pending applications·8 citations·filing 2016–2024
69Inventor score
Top patents by PatentIndex Score
10 records- 0184US10414765B2Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of sameBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·4 cites·8 claims
- 0282US10759794B22-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disordersBayer Pharma AG·Filed 2016·Granted Sep 1, 2020·3 cites·31 claims
- 0376US2025154175A1Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2024·Application pending·0 cites
- 0475US11098063B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2018·Granted Aug 24, 2021·1 cites·13 claims
- 0567US12180227B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 0659US2022259228A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2021·Application pending·0 cites
- 0750US2021024545A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2017·Application pending·0 cites
- 0842US2020093737A1Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapyBayer Pharma AG·Filed 2017·Application pending·0 cites
- 0937US2020085734A1Pharmaceutical dosage forms containing task-i and task-3 channel inhibitors, and the use of same in breathing disorder therapyBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1036US11208422B2Substituted bridged diazepane derivatives and use thereof as TASK-1 and TASK-3 inhibitorsBayer Pharma AG·Filed 2018·Granted Dec 28, 2021·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Björn Rosenstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →